Global Injectable Drug Delivery Devices Market
商品番号 : SMB-71352
| 出版社 | BCC Research |
| 出版年月 | 2025年1月 |
| ページ数 | 166 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
Report Highlights
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
注入型ドラッグデリバリーデバイスの世界市場は、2024 年の 2,165 億ドルから増加し、2024 年から 2029 年までの年間平均成長率 (CAGR) 7.9% で、2029 年までに 3,172 億ドルに達すると推定されています。
Summary:
The injectable drug delivery device industry is crucial in enhancing patient care, improving health outcomes and supporting healthcare providers. Building on technological advances, the industry is increasingly integrating digital health solutions, such as wearable devices, to monitor and manage health conditions more effectively.
Report Scope:
This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.
Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market’s current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $204.2 billion | ||||||||||||||||
| Market size forecast | $317.2 billion | ||||||||||||||||
| Growth rate | CAGR of 7.9% for the forecast period of 2024-2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product, Usage Type, Route of Administration, Therapeutic Application, End User, Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Sweden, Austria, Netherlands, Norway, Switzerland, Hungary, Slovakia, China, India, Japan, Australia, New Zealand, South Korea, Malaysia, Indonesia, Taiwan, Singapore, Vietnam, Indonesia | ||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||
| Companies studied |
| ||||||||||||||||
Report Includes:
– 46 data tables and 62 additional tables
– Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
– Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
– Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
– A Porter’s Five Forces model, and global supply chain and PESTLE analyses
– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
– Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
– A look at the pipeline drugs, clinical trial applications and potential markets for future developments
– Analysis of the competitive landscape, including companies’ market shares, strategic alliances, M&A activities, and a venture funding outlook
– Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
PESTEL Analysis
Porter’s Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Manufacturing
Packaging and Labeling
Distribution and Logistics
Marketing, Sales, and End User
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and Aging Population
Technological Advances
Patient Preference for Self-Administration
Advances in Biologics
Market Restraints
Safety Concerns
Market Opportunities
Emerging Markets
Market Challenges
Patient Compliance and Acceptance
Chapter 4 Regulatory Landscape
Overview
U.S.
EU
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
3D Printing
Nanoparticle Delivery Systems
Biodegradable and Sustained Release Systems
Patent Analysis
Patents by Year
Patents by Applicant
Patents by Owner
Patents by Inventor
Patents by Jurisdiction
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Chapter 6 Market Segmentation Analysis
Segmental Breakdown
Global Market for Injectable Drug Delivery Device
Market Analysis by Product
Conventional Injectable Devices
Advanced Injectable Devices
Market Breakdown by Usage Type
Disposable Injectors
Reusable Injectors
Market Breakdown by Route of Administration
Subcutaneous
Intramuscular
Intravenous
Intradermal
Market Breakdown by Therapeutic Application
Diabetes
Oncology
Autoimmune Diseases
Other Applications
Market Breakdown by End User
Hospital and Clinics
Homecare Settings
Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
Overview
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
Overview
Strategies for Injectable Drug Delivery Device Manufacturers
Distribution Networks
Chapter 9 Appendix
Methodology
Company Profiles
AMGEN INC.
ASTRAZENECA
BD
BAXTER
- BRAUN SE
- HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
LILLY
MERCK & CO. INC.
MEDTRONIC
PFIZER INC.
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TERUMO CORP.
YPSOMED
Abbreviations
Sources
List of Tables
Summary Table : Global Market for Injectable Drug Delivery Device, Through 2029
Table 1 : Diabetes by Region, 2021–2045
Table 2 : Global Incidence of All Cancers, by WHO Region, 2022–2050
Table 3 : Incidence of Cancer Cases, by Cancer Type, 2022
Table 4 : Elderly Population, by Country, 2021 and 2022
Table 5 : Regulatory Approval in the U.S. and Europe
Table 6 : Patents Granted for Injectable Drug Delivery Device, by Applicant, 2021–2024*
Table 7 : Patents Granted for Injectable Drug Delivery Device, by Owner, 2021–2024*
Table 8 : Patents Granted for Injectable Drug Delivery Device, by Inventor, 2021–2024*
Table 9 : Patents Granted for Injectable Drug Delivery Device, by Jurisdiction, 2021–2024*
Table 10 : Clinical Trials in Injectable Drug Delivery Device, by Type of Study, Through November 2024
Table 11 : Clinical Trials in Injectable Drug Delivery Device, by Status, Through October 2024
Table 12 : Clinical Trials in Injectable Drug Delivery Device, by Phase, Through October 2024
Table 13 : Global Market for Injectable Drug Delivery Device, Through 2029
Table 14 : Global Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 15 : Global Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 16 : Global Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 17 : Global Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 18 : Global Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 19 : Global Market for Injectable Drug Delivery Device, by Region, Through 2029
Table 20 : North American Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 21 : North American Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 22 : North American Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 23 : North American Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 24 : North American Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 25 : North American Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 26 : European Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 27 : European Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 28 : European Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 29 : European Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 30 : European Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 31 : European Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 32 : Asia-Pacific Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 33 : Asia-Pacific Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 34 : Asia-Pacific Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 35 : Asia-Pacific Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 36 : Asia-Pacific Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 37 : Asia-Pacific Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 38 : RoW Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 39 : RoW Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 40 : RoW Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 41 : RoW Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 42 : RoW Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 43 : ESG Rankings for Major Injectable Drug Delivery Device Companies, 2024*
Table 44 : ESG: Environmental Overview
Table 45 : ESG: Social Performance Overview
Table 46 : ESG: Governance Overview
Table 47 : Injectable Drug Delivery Device Market: Leading Players
Table 48 : Amgen Inc.: Company Snapshot
Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Amgen Inc.: Product Portfolio
Table 51 : Amgen Inc.: News/Key Developments, 2023
Table 52 : AstraZeneca: Company Snapshot
Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54 : AstraZeneca: Product Portfolio
Table 55 : BD: Company Snapshot
Table 56 : BD: Financial Performance, FY 2022 and 2023
Table 57 : BD: Product Portfolio
Table 58 : BD: News/Key Developments, 2022-2024
Table 59 : Baxter: Company Snapshot
Table 60 : Baxter: Financial Performance, FY 2022 and 2023
Table 61 : Baxter: Product Portfolio
Table 62 : Baxter: News/Key Developments, 2024
Table 63 : B. Braun SE: Company Snapshot
Table 64 : B. Braun SE: Financial Performance, FY 2022 and 2023
Table 65 : B. Braun SE: Product Portfolio
Table 66 : B. Braun SE: News/Key Developments, 2022-2024
Table 67 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 68 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 69 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 70 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 71 : Gerresheimer AG: Company Snapshot
Table 72 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 73 : Gerresheimer AG: Product Portfolio
Table 74 : Gerresheimer AG: News/Key Developments, 2022-2024
Table 75 : Lilly: Company Snapshot
Table 76 : Lilly: Financial Performance, FY 2022 and 2023
Table 77 : Lilly: Product Portfolio
Table 78 : Lilly: News/Key Developments, 2022-2024
Table 79 : Merck & Co. Inc.: Company Snapshot
Table 80 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Merck & Co. Inc.: Product Portfolio
Table 82 : Merck & Co. Inc.: News/Key Developments, 2022 and 2023
Table 83 : Medtronic: Company Snapshot
Table 84 : Medtronic: Financial Performance, FY 2022 and 2023
Table 85 : Medtronic: Product Portfolio
Table 86 : Pfizer Inc.: Company Snapshot
Table 87 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 88 : Pfizer Inc.: Product Portfolio
Table 89 : Pfizer Inc.: News/Key Developments, 2022
Table 90 : Sanofi: Company Snapshot
Table 91 : Sanofi: Financial Performance, FY 2022 and 2023
Table 92 : Sanofi: Product Portfolio
Table 93 : Sanofi: News/Key Developments, 2022-2024
Table 94 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 95 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 96 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 97 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2024
Table 98 : Terumo Corp.: Company Snapshot
Table 99 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 100 : Terumo Corp.: Product Portfolio
Table 101 : Terumo Corp.: News/Key Developments, 2022-2024
Table 102 : Ypsomed: Company Snapshot
Table 103 : Ypsomed: Financial Performance, FY 2022 and 2023
Table 104 : Ypsomed: Product Portfolio
Table 105 : Ypsomed: News/Key Developments, 2022-2024
Table 106 : Abbreviations Used in This Report
Table 107 : Report Sources
List of Figures
Summary Figure : Global Market for Injectable Drug Delivery Device, 2021–2029
Figure 1 : Supply Chain Analysis of Injectable Drug Delivery Device Industry
Figure 2 : Market Dynamics of Injectable Drug Delivery Devices
Figure 3 : Emerging Technologies in the Injectable Drug Delivery Device Market
Figure 4 : Patents Granted for Injectable Drug Delivery Device, by Year, 2021–2024*
Figure 5 : Global Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 6 : Global Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 7 : Global Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 8 : Global Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 9 : Global Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 10 : Global Market Shares of Injectable Drug Delivery Device, by Region, 2023
Figure 11 : North American Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 12 : North American Market for Injectable Drug Delivery Device, 2021-2029
Figure 13 : North American Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 14 : North American Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 15 : North American Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 16 : North American Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 17 : North American Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 18 : European Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 19 : European Market for Injectable Drug Delivery Device, 2021–2029
Figure 20 : European Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 21 : European Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 22 : European Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 23 : European Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 24 : European Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 25 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 26 : Asia-Pacific Market for Injectable Drug Delivery Device, 2021–2029
Figure 27 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 28 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 29 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 30 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 31 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 32 : RoW Market for Injectable Drug Delivery Device, 2021–2029
Figure 33 : RoW Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 34 : RoW Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 35 : RoW Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 36 : RoW Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 37 : RoW Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 38 : ESG Metrics of Injectable Drug Delivery Device Companies
Figure 39 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 40 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 42 : AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 43 : BD: Revenue Share, by Business Unit, FY 2023
Figure 44 : BD: Revenue Share, by Country/Region, FY 2023
Figure 45 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 46 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 47 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 48 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 51 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 52 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 53 : Lilly: Revenue Share, by Business Unit, FY 2023
Figure 54 : Lilly: Revenue Share, by Region, FY 2023
Figure 55 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 56 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 57 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 58 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 59 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 60 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 61 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 62 : Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 63 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, 2023
Figure 65 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 68 : Ypsomed: Revenue Share, by Country/Region, FY 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
